Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Circulation
    July 2021
  1. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    >> Share

    June 2021
  2. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    >> Share

  3. RAYNER BL, Spence JD
    Physiological Treatment of Hypertension in Black Patients: Time for Action.
    Circulation. 2021;143:2367-2369.
    >> Share

  4. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    >> Share

  5. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    >> Share

    May 2021
  6. BROOK RD, Levy PD, Jamerson KA
    Mission "UnACCOMPLISHed": Optimal Antihypertensive Therapy.
    Circulation. 2021;143:1932-1934.
    >> Share

  7. KARIO K, Ferdinand KC, Vongpatanasin W
    Are SGLT2 Inhibitors New Hypertension Drugs?
    Circulation. 2021;143:1750-1753.
    >> Share

    April 2021
  8. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    >> Share

  9. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    >> Share

    March 2021
  10. LI D, Shao NY, Moonen JR, Zhao Z, et al
    ALDH1A3 Coordinates Metabolism with Gene Regulation in Pulmonary Arterial Hypertension.
    Circulation. 2021 Mar 25. doi: 10.1161/CIRCULATIONAHA.120.048845.
    >> Share

  11. ZHU L, Liu F, Hao Q, Feng T, et al
    Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension.
    Circulation. 2021 Mar 4. doi: 10.1161/CIRCULATIONAHA.120.046542.
    >> Share

    February 2021
  12. KUEHN BM
    Rising Prepregnancy Hypertension, Preeclampsia Disparities Raise Alarm.
    Circulation. 2021;143:753-754.
    >> Share

  13. SUDHARSANAN N, Theilmann M, Kirschbaum TK, Manne-Goehler J, et al
    Variation in the Proportion of Adults in Need of BP-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1,037,215 Individuals from 50 Nationally Representative Surveys.
    Circulation. 2021 Feb 8. doi: 10.1161/CIRCULATIONAHA.120.051620.
    >> Share

    January 2021
  14. MCEVOY JW
    Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e20-e21.
    >> Share

  15. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
    Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e22-e23.
    >> Share

    December 2020
  16. BOGUSLAVSKYI A, Tokar S, Prysyazhna O, Rudyk O, et al
    Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure and Hypertension in Mice and Man.
    Circulation. 2020 Dec 18. doi: 10.1161/CIRCULATIONAHA.119.040557.
    >> Share

    November 2020
  17. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
    Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
    >> Share

    October 2020

  18. Correction to: Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020;142:e235.
    >> Share

  19. ZHANG DY, Cheng YB, Guo QH, Shan XL, et al
    Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Circulation. 2020 Oct 6. doi: 10.1161/CIRCULATIONAHA.120.046685.
    >> Share

  20. LACKLAND DT, Howard VJ, Cushman M, Oparil S, et al
    Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.
    Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.048063.
    >> Share

    September 2020
  21. CUI C, Fan J, Zeng Q, Cai J, et al
    CD4(+) T-Cell Endogenous Cystathionine gamma Lyase-Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation.
    Circulation. 2020 Sep 9. doi: 10.1161/CIRCULATIONAHA.119.045344.
    >> Share

    August 2020
  22. HONIGBERG MC, Chaffin M, Aragam K, Bhatt DL, et al
    Genetic Variation in Cardiometabolic Traits and Medication Targets and the Risk of Hypertensive Disorders of Pregnancy.
    Circulation. 2020;142:711-713.
    >> Share

    July 2020
  23. SHEN H, Zhang J, Wang C, Jain PP, et al
    MDM2-Mediated Ubiquitination of ACE2 Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 28. doi: 10.1161/CIRCULATIONAHA.120.048191.
    >> Share

  24. OMURA J, Habbout K, Shimauchi T, Wu WH, et al
    Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.047626.
    >> Share

  25. GUO C, Zeng Y, Chang LY, Yu Z, et al
    Independent and Opposing Associations of Habitual Exercise and Chronic PM2.5 Exposures on Hypertension Incidence.
    Circulation. 2020 Jul 20. doi: 10.1161/CIRCULATIONAHA.120.045915.
    >> Share

  26. HAYNES N, Cooper LA, Albert MA
    At the Heart of the Matter: Unmasking and Addressing the Toll of COVID-19 on Diverse Populations.
    Circulation. 2020;142:105-107.
    >> Share

    June 2020
  27. MESSERLI FH, Siontis GCM, Rexhaj E
    COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Circulation. 2020;141:2042-2044.
    >> Share

  28. ERCU M, Marko L, Schachterle C, Tsvetkov D, et al
    Phosphodiesterase 3A and Arterial Hypertension.
    Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.043061.
    >> Share

  29. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    >> Share

    May 2020
  30. HOFFMANN F, Limper U, Zaha VG, Reuter H, et al
    Evolution of Pulmonary Hypertension During Severe Sustained Hypoxia.
    Circulation. 2020;141:1504-1506.
    >> Share

    April 2020
  31. FULTON DJR, Stepp DW
    Origins of Hypertension in Obesity: Plain Vanilla(oid) or Multiple Flavors?
    Circulation. 2020;141:1334-1337.
    >> Share

  32. SIEDLINSKI M, Jozefczuk E, Xu X, Teumer A, et al
    White Blood Cells and Blood Pressure: A Mendelian Randomization Study.
    Circulation. 2020;141:1307-1317.
    >> Share

  33. OTTOLINI M, Hong K, Cope EL, Daneva Z, et al
    Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity.
    Circulation. 2020;141:1318-1333.
    >> Share

  34. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    >> Share

    March 2020
  35. WHITE WB, Wolfson L
    Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e652-e653.
    >> Share

  36. RIVASI G, Mossello E, Ungar A
    Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
    Circulation. 2020;141:e650-e651.
    >> Share

  37. POTUS F, Pauciulo MW, Cook EK, Zhu N, et al
    Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.
    Circulation. 2020 Mar 20. doi: 10.1161/CIRCULATIONAHA.119.044320.
    >> Share

  38. JEFFERSON AL
    Midlife Consequences of Cumulative Blood Pressure Exposure: Importance of a Lifespan Approach.
    Circulation. 2020;141:725-727.
    >> Share

  39. SCHIMMEL K, Jung M, Foinquinos A, Jose GS, et al
    Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
    Circulation. 2020;141:751-767.
    >> Share

  40. MAHINRAD S, Kurian S, Garner CR, Sedaghat S, et al
    Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife.
    Circulation. 2020;141:712-724.
    >> Share

    February 2020
  41. KUEHN BM
    Race May Influence Transplant Decision Making in Heart Failure: Studies Also Detail Disparities in Hypertension Diagnosis, Statin Prescribing.
    Circulation. 2020;141:694-695.
    >> Share

  42. ROSENKRANZ S, Howard LS, Gomberg-Maitland M, Hoeper MM, et al
    Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.
    Circulation. 2020;141:678-693.
    >> Share

  43. KAYE DM, Shihata W, Jama HA, Tsyganov K, et al
    Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.
    Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081.
    >> Share

  44. JACKEVICIUS CA, Krumholz HM, Chong A, Koh M, et al
    Population Impact of Generic Valsartan Recall.
    Circulation. 2020;141:411-413.
    >> Share

    January 2020
  45. VALENZUELA PL, Ruilope LM, Lucia A
    Muscling in on Resistant Hypertension.
    Circulation. 2020;141:240-242.
    >> Share

  46. AGDAMAG AC, Krishnappa D, Benditt DG
    ST-Segment Changes After Loss of Consciousness.
    Circulation. 2020;141:80-82.
    >> Share

  47. ANDERSEN K, Hallmarker U, James S, Sundstrom J, et al
    Long-Distance Skiing and Incidence of Hypertension: A Cohort Study of 206,889 Participants in a Long-Distance Cross-Country Skiing Event.
    Circulation. 2020 Jan 6. doi: 10.1161/CIRCULATIONAHA.119.042208.
    >> Share

  48. GERGES C, Gerges M, Friewald R, Fesler P, et al
    Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Circulation. 2020 Jan 3. doi: 10.1161/CIRCULATIONAHA.119.041515.
    >> Share

  49. KONG D, Wan Q, Li J, Zuo S, et al
    DP1 Activation Reverses Age-Related Hypertension via NEDD4L-Mediated T-bet Degradation in T Cells.
    Circulation. 2020 Jan 2. doi: 10.1161/CIRCULATIONAHA.119.042532.
    >> Share

    December 2019
  50. GRANDI SM, Smith GN, Platt RW
    The Relative Contribution of Pregnancy Complications to Cardiovascular Risk Prediction: Are We Getting It Wrong?
    Circulation. 2019;140:1965-1967.
    >> Share

    November 2019
  51. TONG D, Schiattarella GG, Jiang N, May HI, et al
    Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1769-1771.
    >> Share

  52. PANDEY A, Patel KV, Vongpatanasin W, Ayers C, et al
    Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043337.
    >> Share

    October 2019
  53. PENG J, Vongpatanasin W, Sacharidou A, Kifer D, et al
    Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
    Circulation. 2019 Oct 10. doi: 10.1161/CIRCULATIONAHA.119.043490.
    >> Share


  54. Correction to: Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2019;140:e718.
    >> Share

  55. RUOPP NF, Farber HW
    The New World Symposium on Pulmonary Hypertension Guidelines: Should Twenty-One Be the New Twenty-Five?
    Circulation. 2019;140:1134-1136.
    >> Share

  56. DIAZ R, Tajer C
    Current Status and Future Strategies for Cardiovascular Disease in Argentina.
    Circulation. 2019;140:1137-1139.
    >> Share

    September 2019
  57. SUPIANO MA, Williamson JD
    New Guidelines and SPRINT Results: Implications for Geriatric Hypertension.
    Circulation. 2019;140:976-978.
    >> Share

  58. COCKBAIN B, Price LC, Hind M
    Bony Breathlessness: Reversible Pulmonary Hypertension in Melnick-Needles Syndrome Using Noninvasive Ventilation
    Circulation. 2019;140:880-885.
    >> Share

    August 2019
  59. TIAN W, Jiang X, Sung YK, Shuffle E, et al
    Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 (Bmpr2) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation.
    Circulation. 2019 Aug 29. doi: 10.1161/CIRCULATIONAHA.119.040629.
    >> Share

  60. NAEIJE R, Chin K
    Differentiating Precapillary From Postcapillary Pulmonary Hypertension.
    Circulation. 2019;140:712-714.
    >> Share

  61. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
    Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
    Circulation. 2019;140:705-707.
    >> Share

  62. NADEAU V, Bonnet S, Paulin R
    Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e286-e287.
    >> Share

  63. MENDES-FERREIRA P, Manaud G, Perros F
    Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e288-e289.
    >> Share

    July 2019
  64. STRANDBERG TE
    Blood Pressure in a 100-Year Perspective.
    Circulation. 2019;140:101-102.
    >> Share

    June 2019
  65. GILL D, Georgakis MK, Koskeridis F, Jiang L, et al
    Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.
    Circulation. 2019 Jun 25. doi: 10.1161/CIRCULATIONAHA.118.038814.
    >> Share

  66. OLDE RIKKERT MGM, Fernandes M
    Letter by Olde Rikkert and Fernandes Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1021-e1022.
    >> Share

  67. RUEDA-OCHOA OL, Rizopoulos D, Kavousi M
    Letter by Rueda-Ochoa et al Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1019-e1020.
    >> Share

    May 2019
  68. SEPEHRVAND N, Alemayehu W, Dyck GJB, Dyck JRB, et al
    External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
    Circulation. 2019;139:2377-2379.
    >> Share

  69. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    >> Share

  70. KIM B, Arany Z
    Does Glycine cataBOLAsm Drive Pulmonary Hypertension?
    Circulation. 2019;139:2256-2259.
    >> Share

    April 2019
  71. JAMERSON KA
    Should Certain Antihyperglycemic Medications Be Preferred Over Antihypertensive Medications for Blood Pressure Control in Special Populations With Diabetes Mellitus?
    Circulation. 2019;139:2110-2112.
    >> Share

  72. FERDINAND KC, Balavoine F, Besse B, Black HR, et al
    Efficacy and Safety of Firibastat, a First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins A Phase 2, Open-Label, Multicenter, Dose-Titrating Study.
    Circulation. 2019 Apr 24. doi: 10.1161/CIRCULATIONAHA.119.040070.
    >> Share

  73. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    >> Share

  74. CHIN KM, Rubin LJ, Channick R, Di Scala L, et al
    Association of NT-proBNP and Long-Term Outcome in Patients with Pulmonary Arterial Hypertension: Insights from the Phase III GRIPHON Study.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039360.
    >> Share

  75. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    >> Share

  76. ZHAO D, Post WS, Blasco-Colmenares E, Cheng A, et al
    Racial Differences in Sudden Cardiac Death.
    Circulation. 2019;139:1688-1697.
    >> Share

    March 2019
  77. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451.
    >> Share

  78. COVASSIN N, Somers VK
    From Resistant Airway to Resistant Hypertension.
    Circulation. 2019;139:1285-1288.
    >> Share

  79. JOHNSON DA, Thomas SJ, Abdalla M, Guo N, et al
    Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
    Circulation. 2019;139:1275-1284.
    >> Share

    February 2019
  80. FERDINAND KC, Izzo JL, Lee J, Meng L, et al
    Antihyperglycemic and Blood Pressure Effects of Empagliflozin in African Americans with Type 2 Diabetes and Hypertension.
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.036568.
    >> Share

  81. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    >> Share

  82. YU Q, Tai YY, Tang Y, Zhao J, et al
    BOLA3 Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.035889.
    >> Share

    January 2019
  83. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    >> Share

  84. SCHOMBURG L, Melander O
    Letter by Schomburg and Melander Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:722-723.
    >> Share

  85. KIKUCHI N, Satoh K, Saito Y, Shimokawa H, et al
    Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:724-725.
    >> Share

  86. RAM CVS
    Status of Renal Denervation Therapy for Hypertension.
    Circulation. 2019;139:601-603.
    >> Share


  87. Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2019;139:e3.
    >> Share


  88. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    >> Share

  89. FERDINAND KC, Graham RM
    Uncontrolled Hypertension in Black Men.
    Circulation. 2019;139:20-23.
    >> Share

  90. VICTOR RG, Blyler CA, Li N, Lynch K, et al
    Sustainability of Blood Pressure Reduction in Black Barbershops.
    Circulation. 2019;139:10-19.
    >> Share

  91. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    >> Share

    December 2018
  92. YUAN K, Shamskhou EA, Orcholski ME, Nathan A, et al
    Loss of Endothelial Derived WNT5A is Associated with Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Circulation. 2018 Dec 11. doi: 10.1161/CIRCULATIONAHA.118.037642.
    >> Share

  93. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    >> Share

    November 2018
  94. KARIO K, Okada K, Kato M, Nishizawa M, et al
    24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.037076.
    >> Share

  95. KIM HC, Jeon YW, Heo ST
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines.
    Circulation. 2018;138:2312-2314.
    >> Share

    October 2018
  96. FUDIM M, Jones WS
    New Curveball for Hypertension Guidelines?
    Circulation. 2018;138:1815-1818.
    >> Share

  97. WRIGHT JT JR, Carey RM, Bolen SD
    First-Year Anniversary of the 2017 Hypertension Guideline.
    Circulation. 2018;138:1774-1776.
    >> Share

  98. BAI G, Bennet C, Wang J, Anderson GF, et al
    Access to Antihypertensive Drugs in China.
    Circulation. 2018;138:1777-1779.
    >> Share

  99. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    >> Share

  100. HAUTEFORT A, Mendes-Ferreira P, Sabourin J, Manaud G, et al
    Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Circulation. 2018 Oct 4. doi: 10.1161/CIRCULATIONAHA.118.033744.
    >> Share

  101. YANG X, Zhang R, Wang D
    Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1488-1489.
    >> Share

  102. SCHIAVON CA, Ikeoka D, Santucci EV, Santos RN, et al
    Response by Schiavon et al to Letters Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1492-1493.
    >> Share

  103. MORIS D, Cerullo M, Guerron AD
    Letter by Moris et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1490-1491.
    >> Share

  104. MARQUES FZ
    Missing Heritability of Hypertension and Our Microbiome.
    Circulation. 2018;138:1381-1383.
    >> Share

    September 2018
  105. FENGLER K, Rommel KP, Blazek S, Besler C, et al
    A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension (RADIOSOUND-HTN).
    Circulation. 2018 Sep 25. doi: 10.1161/CIRCULATIONAHA.118.037654.
    >> Share

    August 2018
  106. BONNET S, Paulin R, Boucherat O
    Small SeP or Giant Leap for Pulmonary Hypertension Research?
    Circulation. 2018;138:624-626.
    >> Share

    May 2018
  107. HADINNAPOLA C, Graf S, Morrell NW
    Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2413-2414.
    >> Share

  108. HERNANDEZ-GONZALEZ I, Navas P, Escribano-Subias P
    Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2411-2412.
    >> Share

  109. WHITE RJ, Wilkins MR
    New Therapeutic Approaches in Pulmonary Arterial Hypertension: The Pantheon Is Getting Crowded.
    Circulation. 2018;137:2390-2392.
    >> Share

  110. CAMPBELL NRC, Zhang XH
    Hypertension in China: Time to Transition From Knowing the Problem to Implementing the Solution.
    Circulation. 2018;137:2357-2359.
    >> Share

  111. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    >> Share

  112. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    >> Share

    April 2018
  113. DE LA SIERRA A, Banegas JR, Vinyoles E, Segura J, et al
    Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.
    Circulation. 2018 Apr 30. pii: CIRCULATIONAHA.118.034619.
    >> Share

  114. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    >> Share

  115. KIKUCHI N, Satoh K, Kurosawa R, Yaoita N, et al
    Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.
    Circulation. 2018 Apr 10. pii: CIRCULATIONAHA.117.033113.
    >> Share

    March 2018
  116. SOLIMAN EZ, Ambrosius WT, Lewis CE
    Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1300-1301.
    >> Share

  117. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1299.
    >> Share

  118. LEWIS GA, Schelbert EB, Miller CA
    Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1297-1298.
    >> Share

  119. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    >> Share

  120. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    >> Share

  121. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    >> Share

  122. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    >> Share

  123. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    >> Share

    February 2018
  124. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    >> Share

  125. MANCIA G, Corrao G
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Italy.
    Circulation. 2018;137:889-890.
    >> Share

  126. BRUNSTROM M, Carlberg B, Lindholm LH
    Perspective From Sweden on the Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A "Sprint" Beyond Evidence in the United States.
    Circulation. 2018;137:886-888.
    >> Share

  127. SCHIFFRIN EL
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Canada.
    Circulation. 2018;137:883-885.
    >> Share

  128. WANG Z, Chen Z, Zhang L, Wang X, et al
    Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015.
    Circulation. 2018 Feb 15. pii: CIRCULATIONAHA.117.032380.
    >> Share

  129. DUMAS SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, et al
    NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.029930.
    >> Share

  130. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    >> Share

  131. COOPER R
    Hypertension, Genes, and Environment: Challenges for Prevention and Risk Prediction.
    Circulation. 2018;137:662-664.
    >> Share

  132. WANDER GS, Ram CVS
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.
    Circulation. 2018;137:549-550.
    >> Share

  133. WANG JG, Liu L
    Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.
    Circulation. 2018;137:546-548.
    >> Share

  134. KARIO K
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.
    Circulation. 2018;137:543-545.
    >> Share

  135. CHEN KH, Dasgupta A, Lin J, Potus F, et al
    Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Circulation. 2018 Feb 5. pii: CIRCULATIONAHA.117.031258.
    >> Share

    January 2018
  136. SUGLIA SF, Koenen KC, Boynton-Jarrett R, Chan PS, et al
    Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2018;137:e15-e28.
    >> Share

  137. HSU S, Kokkonen-Simon KM, Kirk JA, Kolb TM, et al
    Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.033147.
    >> Share

  138. JACKSON SL, Cogswell ME, Zhao L, Terry AL, et al
    Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults in the United States: National Health and Nutrition Examination Survey, 2014.
    Circulation. 2018;137:237-246.
    >> Share

  139. ZANCHETTI A, Thomopoulos C
    Benefits and Risks of Antihypertensive Treatment: How Far Can Diastolic Blood Pressure Be Lowered?
    Circulation. 2018;137:144-147.
    >> Share

  140. MUNTNER P, Carey RM, Gidding S, Jones DW, et al
    Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Circulation. 2018;137:109-118.
    >> Share

  141. BEDDHU S, Chertow GM, Cheung AK, Cushman WC, et al
    Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Circulation. 2018;137:134-143.
    >> Share

  142. BOYD HA, Basit S, Wohlfahrt J, Oyen N, et al
    Response by Boyd et al to Letter Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:97-98.
    >> Share

  143. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:95-96.
    >> Share

    December 2017
  144. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    >> Share

  145. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    >> Share

  146. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    >> Share

  147. KALKMAN DN, Brouwer TF, Vehmeijer JT, Berger WR, et al
    J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Circulation. 2017;136:2220-2229.
    >> Share

    November 2017
  148. CAILLON A, Huo KG, Paradis P, Schiffrin EL, et al
    Response by Caillon et al to Letter Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2200-2201.
    >> Share

  149. CAMPBELL DJ
    Letter by Campbell Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2198-2199.
    >> Share

  150. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    >> Share

  151. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    >> Share

  152. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    >> Share

  153. SCHIAVON CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, et al
    Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032130.
    >> Share

  154. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    >> Share

    October 2017
  155. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    >> Share

  156. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    >> Share

  157. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    >> Share

    September 2017
  158. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    >> Share

  159. NIIRANEN TJ, Larson MG, McCabe EL, Xanthakis V, et al
    Prognosis of Prehypertension Without Progression to Hypertension.
    Circulation. 2017;136:1262-1264.
    >> Share

  160. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    >> Share

  161. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    >> Share

  162. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    >> Share

  163. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    >> Share

    August 2017
  164. LI H, Cai J, Chen R, Zhao Z, et al
    Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification.
    Circulation. 2017;136:618-627.
    >> Share

  165. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    >> Share


  166. Correction to: Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Circulation. 2017;136:e136.
    >> Share

    July 2017
  167. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    >> Share

    June 2017
  168. STERGIOU GS, Ntineri A, Kollias A
    Defining Ambulatory Blood Pressure Thresholds for Decision Making in Hypertension: The Effect of Race and Methodology.
    Circulation. 2017;135:2481-2484.
    >> Share

  169. RAVENELL J, Shimbo D, Booth JN 3rd, Sarpong DF, et al
    Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Circulation. 2017;135:2470-2480.
    >> Share

  170. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    >> Share

  171. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    >> Share

  172. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    >> Share

    May 2017
  173. SAG CM, Schnelle M, Zhang J, Murdoch CE, et al
    Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
    Circulation. 2017;135:2163-2177.
    >> Share

  174. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    >> Share

  175. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    >> Share

    April 2017
  176. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    >> Share

  177. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    >> Share

  178. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    >> Share

  179. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    >> Share

    March 2017
  180. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    >> Share

  181. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    >> Share

  182. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    >> Share

    January 2017
  183. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    >> Share

    November 2016
  184. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    >> Share

  185. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    >> Share

  186. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    >> Share

    October 2016
  187. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    >> Share

    August 2016
  188. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016